MedTrace Logo

Epidemiological Study to Describe Non-small-cell Lung Carcinoma (NSCLC) Clinical Management Patterns in MENA. Lung-EPICLIN/ KSA

NCT01330862 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 54

Last updated 2012-12-12

No results posted yet for this study

Summary

The study is to provide accurate, reliable information on NSCLC clinical management across MENA (Middle East North Africa) countries in order to detect unmet medical needs of this disease, it is a purely observational study; therefore patients are not assigned to a particular therapeutic strategy beforehand by a protocol. Treatment will be according to current clinical practice.

Conditions

  • NSCLC Patient Characteristics

Sponsors & Collaborators

Principal Investigators

  • Dr. Abdul Rahman Jazieh · King Fahad National Guard Hospital

  • Dr. Ahmed Abdulwarith · King Fahad Specialist Hospital

  • Dr. Rasha Moastafa · King Fahad Medical City

  • Dr. Sherif Wafa · Prince Faisal Bin Bander oncology centre

  • Dr. Maged Mansour · Dr. Erfan & Bagedo Hospital

  • Dr. Mohamed Rahhal · King Fahad Specialist Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2013-03-31
Completion
2013-03-31

Countries

  • Saudi Arabia

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01330862 on ClinicalTrials.gov